Dr. Rafeyan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 S Michigan Ave
# B-390
Chicago, IL 60616Phone+1 312-567-6691Fax+1 312-328-7895
Summary
- Dr. Roueen Rafeyan is a seasoned Psychiatry professional who is currently located in Chicago, Illinois. He specialized in Psychiatry with a subspecialty in Addiction and completed his residency at the University of Illinois College of Medicine at Chicago. Dr. Rafeyan has extensive experience in addiction medicine and behavioral neurology/neuropsychiatry. He currently serves as the Chief Medical Officer at Gateway Foundation Addiction Recovery Center and runs his private practice, Roueen Rafeyan Md Ltd. In addition to his patient care roles, he has published numerous works in The Journal of Clinical Psychiatry and Pharmacology & Therapeutics on various topics, including major depressive disorder and schizophrenia. Recognizing his contributions to the field, Dr. Rafeyan has received multiple accolades, such as Fellow American Society of Addiction Medicine, Distinguished Fellow from the American Psychiatric Association, and Regional Top Doctor from Castle Connolly.
Education & Training
- University of Illinois College of Medicine at ChicagoResidency, Psychiatry, 1992 - 1996
- Istanbul University FomClass of 1989
Certifications & Licensure
- IL State Medical License 1992 - 2026
- IN State Medical License 1996 - 2025
- FL State Medical License 2019 - 2021
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Preventive Medicine Addiction Medicine
- American Board of Addiction MedicineBoard Certification
Awards, Honors, & Recognition
- Fellow American Society of Addiction Medicine ASAM, 2017
- Distinguished Fellow American Psychiatric Association, 2010
- Top Doctor Consumer Report, 2007
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsMirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedsideSteven M. Graves, Roueen Rafeyan, Jeffrey Watts, T. Celeste Napier
Pharmacology & Therapeutics. 2012-12-01 - 12 citationsPatient Functioning, Life Engagement, and Treatment Goals in Schizophrenia.Christoph U Correll, Zahinoor Ismail, Roger S McIntyre, Roueen Rafeyan, Michael E Thase
The Journal of Clinical Psychiatry. 2022-08-17 - 7 citationsPatient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia.Christoph U Correll, Zahinoor Ismail, Roger S McIntyre, Roueen Rafeyan, Michael E Thase
The Journal of Clinical Psychiatry. 2022-08-03
Press Mentions
- Deadly Synthetic ‘ISO’ Implicated in at Least 19 U.S. DeathsSeptember 16th, 2020
- Deadly Opioid 'ISO' Implicated in at Least 19 Overdoses in US After China Bans FentanylSeptember 1st, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: